Sungman Cha

Title: Innovations by Inventor Sungman Cha

Introduction

Sungman Cha is a notable inventor based in Providence, RI (US). He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that address critical health issues. With a total of 2 patents, his work focuses on enhancing the efficacy of antiviral and anticancer drugs.

Latest Patents

Sungman Cha's latest patents include the development of 5-benzyl barbiturate derivatives. These compounds are designed for use as water-soluble uridine phosphorylase inhibitors. They are particularly useful in reducing the toxicity and anemia induced by antiviral drugs such as AZT. Additionally, these compounds have the potential to enhance the effectiveness of anticancer drugs while mitigating their host-toxicity. Another significant patent involves hydroxymethyl derivatives of 5-benzylacyclouridine, which includes a compound of the Formula (I) where X is a benzyl group or a benzyloxybenzyl group, along with pharmaceutical preparations containing the same.

Career Highlights

Sungman Cha is affiliated with Brown University, where he continues to engage in innovative research. His work has garnered attention for its potential impact on improving patient outcomes in the treatment of various diseases.

Collaborations

Some of his notable coworkers include Mahmoud H El Kouni and Fardos N Naguib, who contribute to the collaborative research environment at Brown University.

Conclusion

Sungman Cha's contributions to pharmaceutical innovations highlight the importance of research in developing effective treatments for serious health conditions. His work exemplifies the intersection of science and practical application in medicine.